WallStreetZenWallStreetZen

NASDAQ: CCAP
Crescent Capital Bdc Inc Stock Forecast, Predictions & Price Target

Analyst price target for CCAP

Based on 2 analysts offering 12 month price targets for Crescent Capital Bdc Inc.
Min Forecast
$16.50-4.4%
Avg Forecast
$17.75+2.84%
Max Forecast
$19.00+10.08%

Should I buy or sell CCAP stock?

Based on 2 analysts offering ratings for Crescent Capital Bdc Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their CCAP stock forecasts and price targets.

CCAP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-23
lockedlocked$00.00+00.00%2024-01-29

1 of 1

Forecast return on equity

Is CCAP forecast to generate an efficient return?

Forecast return on assets

Is CCAP forecast to generate an efficient return on assets?

CCAP revenue forecast

What is CCAP's revenue in the next 2 years based on estimates from 2 analysts?
Avg 1 year Forecast
$187.0M+1.53%
Avg 2 year Forecast
$171.9M-6.63%
CCAP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

CCAP revenue growth forecast

How is CCAP forecast to perform vs Asset Management companies and vs the US market?
Company
1.53%
Industry
-5.27%
Market
13.86%
CCAP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
CCAP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

CCAP vs Asset Management Stocks

TickerPricePrice TargetUp/downsideConsensus
CCAP$17.26$17.75+2.84%Buy
VINP$11.30$15.00+32.74%Strong Buy
FDUS$19.74$22.00+11.45%Hold
ALTI$5.66$9.00+59.01%Strong Buy
TCPC$10.43$11.00+5.47%Hold

Crescent Capital Bdc Stock Forecast FAQ

Is Crescent Capital Bdc Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: CCAP) stock is to Buy CCAP stock.

Out of 2 analysts, 0 (0%) are recommending CCAP as a Strong Buy, 1 (50%) are recommending CCAP as a Buy, 1 (50%) are recommending CCAP as a Hold, 0 (0%) are recommending CCAP as a Sell, and 0 (0%) are recommending CCAP as a Strong Sell.

If you're new to stock investing, here's how to buy Crescent Capital Bdc stock.

What is CCAP's revenue growth forecast for 2024-2025?

(NASDAQ: CCAP) Crescent Capital Bdc's forecast annual revenue growth rate of 1.53% is forecast to beat the US Asset Management industry's average forecast revenue growth rate of -5.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.86%.

Crescent Capital Bdc's revenue in 2024 is $184,134,000.On average, 2 Wall Street analysts forecast CCAP's revenue for 2024 to be $6,928,841,519, with the lowest CCAP revenue forecast at $6,875,287,584, and the highest CCAP revenue forecast at $6,982,395,455.

In 2025, CCAP is forecast to generate $6,371,806,468 in revenue, with the lowest revenue forecast at $6,203,732,352 and the highest revenue forecast at $6,539,880,584.

What is CCAP's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: CCAP) forecast ROA is N/A, which is lower than the forecast US Asset Management industry average of 2.33%.

What is CCAP's Price Target?

According to 2 Wall Street analysts that have issued a 1 year CCAP price target, the average CCAP price target is $17.75, with the highest CCAP stock price forecast at $19.00 and the lowest CCAP stock price forecast at $16.50.

On average, Wall Street analysts predict that Crescent Capital Bdc's share price could reach $17.75 by Feb 23, 2025. The average Crescent Capital Bdc stock price prediction forecasts a potential upside of 2.84% from the current CCAP share price of $17.26.

What is CCAP's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: CCAP) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.